| Literature DB >> 31584447 |
Serkan Kahraman1, Ali Kemal Kalkan1, Ayse Beril Turkyilmaz1, Arda Can Dogan1, Yalcin Avci1, Fatih Uzun1, Mehmet Erturk1.
Abstract
OBJECTIVE: Fractional flow reserve (FFR) measurement is used to decide the hemodynamic significance of coronary artery lesion. QRS-T angle (QRSTa) is a novel marker of myocardial repolarization abnormality and is affected by obstructive coronary artery disease. The aim of the present study was to evaluate the association between QRSTa and coronary FFR measurement in patients with isolated left anterior descending (LAD) artery stenosis.Entities:
Mesh:
Year: 2019 PMID: 31584447 PMCID: PMC6955084 DOI: 10.14744/AnatolJCardiol.2019.99692
Source DB: PubMed Journal: Anatol J Cardiol ISSN: 2149-2263 Impact factor: 1.596
Figure 1An ECG example demonstrating the measurement of the frontal QRS-T angle. The QRS axis and T axis were calculated automatically (arrowheads). Then, the frontal QRSTa was calculated as the absolute value of the difference between the frontal plane QRS and T axes (frontal QRS-T angle=|QRS axis−T axis|). For the ECG of the patient demonstrating above, frontal QRS-T angle=|46° (QRS axis)−44° (T axis)|=2°
ECG - electrocardiography
Basal demographic and clinical factors of the normal and low FFR groups
| Normal FFR (>0.80) (n=139) | Low FFR (≤0.80) (n=58) | ||
|---|---|---|---|
| Age | 61±11 | 64±11 | |
| Gender (female), n (%) | 36 (50%) | 31 (18%) | 0.507 |
| Smoking, n (%) | 38 (27.3%) | 12 (20.7%) | 0.328 |
| Diabetes mellitus, n (%) | 41 (29.5%) | 17 (29.3%) | 0.979 |
| Hypertension, n (%) | 74 (53.2%) | 30 (51.7%) | 0.846 |
| Hyperlipidemia, n (%) | 60 (43.2%) | 24 (41.4%) | 0.817 |
| Peripheral arterial disease, n (%) | 6 (4.3%) | 1 (1.7%) | 0.337 |
| Atrial fibrillation, n (%) | 11 (7.9%) | 3 (5.2%) | 0.366 |
| Hemoglobin (g/dL) | 13.8±1.7 | 13.6±2.0 | 0.437 |
| Leukocyte (×103/mm3) | 8.0 (6.80-9.80) | 7.85 (6.80-9.48) | 0.713 |
| Thrombocyte (×103/mm3) | 251±66 | 260±74 | 0.387 |
| Creatinine (mg/dL) | 0.80 (0.70-0.97) | 0.85 (0.70-0.94) | 0.837 |
| Total cholesterol (mg/dL) | 193±46 | 188±52 | 0.560 |
| LDL cholesterol (mg/dL) | 121 (90-143) | 114 (87-140) | 0.322 |
| HDL cholesterol (mg/dL) | 43 (38-51) | 41 (32-50) | 0.168 |
| Triglyceride (mg/dL) | 138 (108-208) | 145 (98-219) | 0.967 |
| Medication usage, n (%) | |||
| Beta-blocker | 48 (34.5%) | 19 (32.8%) | 0.811 |
| ACEI | 47 (33.8%) | 19 (32.8%) | 0.886 |
| ARB | 1 (0.7%) | 0 (0%) | 0.706 |
| Calcium channel blocker | 6 (4.3%) | 5 (8.6%) | 0.192 |
| Statin | 15 (10.8%) | 7 (12.1%) | 0.795 |
| BMI (kg/m2) | 23.3 (21.0-26.0) | 24.0 (21.5-28.0) | 0.761 |
| LVEDD (mm) | 49 (45-50) | 48 (45-51) | 0.791 |
| LVESD (mm) | 30 (28-35) | 31 (29-34) | 0.264 |
| IVS thickness (mm) | 9 (8-10) | 9 (8-10) | 0.238 |
| Ejection fraction % | 60 (55-63) | 60 (55-63) | 0.765 |
| Adenosine dosage (µg) | 250 (200-300) | 225 (200-300) | |
| Pre-procedural FFR value | 0.94 (0.92-0.96) | 0.89 (0.85-0.93) | |
| Post-procedural FFR value | 0.87 (0.83-0.90) | 0.76 (0.73-0.79) | |
ACEI - angiotensin-converting enzyme inhibitor; ARB - angiotensin receptor blocker; BMI - body mass index; FFR - fractional flow reserve; HDL - high-density lipoprotein;
IVS - interventricular septum; LDL - low-density lipoprotein; LVEDD - left ventricle end-diastolic diameter; LVESD - left ventricle end-systolic diameter
Electrocardiographic parameters of patients with normal and low FFR
| Normal FFR (>0.80) (n=139) | Low FFR (≤0.80) (n=58) | ||
|---|---|---|---|
| Heart rate (beat/min) | 76 (71-85) | 79 (69-90) | 0.477 |
| QRS duration (ms) | 81 (76-86) | 76 (74-85) | 0.358 |
| QT interval (ms) | 377 (370-385) | 379 (373-386) | |
| QTc interval (ms) | 430±31 | 438±44 | 0.261 |
| Frontal QRS-T angle | 59 (56-86) | 86 (62-99) | |
| QRS-T angle >63.5°, n (%) | 60 (43.2%) | 43 (74.1%) | |
| QRS-T angle <63.5°, n (%) | 79 (56.8%) | 15 (25.9%) | |
| Frontal QRS-T angle | 80.24±58 | 76.28±58 | |
Based on 58 patients undergoing revascularization. FFR - fractional flow reserve
Figure 2The comparison of QT interval and QRSTa of the normal and low FFR groups
FFR - fractional flow reserve; QRSTa - QRS-T angle
Multivariate logistic regression analysis showing the independent predictors of the functional significance of coronary lesion
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| Odds ratio | 95% CI (lower–upper) | Odds ratio | 95% CI (lower–upper) | |||
| Age | 1.025 | 0.992-1.059 | 0.135 | |||
| Gender | 1.248 | 0.648-2.404 | 0.507 | - | - | - |
| Smoking | 1.442 | 0.690-3.013 | 0.330 | - | - | - |
| Diabetes mellitus | 1.009 | 0.515-1.977 | 0.979 | - | - | - |
| Hypertension | 1.063 | 0.575-1.962 | 0.846 | - | - | - |
| Hyperlipidemia | 1.076 | 0.578-2.002 | 0.817 | - | - | - |
| Peripheral arterial disease | 2.571 | 0.303-21.847 | 0.387 | - | - | - |
| Atrial fibrillation | 1.576 | 0.423-5.869 | 0.498 | - | - | - |
| Hemoglobin | 0.934 | 0.786-1.109 | 0.435 | - | - | - |
| Leukocyte | 0.991 | 0.885-1.111 | 0.883 | - | - | - |
| Thrombocyte | 1.002 | 0.998-1.006 | 0.386 | - | - | - |
| Creatinine | 1.608 | 0.429-6.030 | 0.481 | - | - | - |
| Total cholesterol | 0.998 | 0.992-1.005 | 0.558 | - | - | - |
| LDL cholesterol | 0.997 | 0.990-1.004 | 0.407 | - | - | - |
| HDL cholesterol | 0.978 | 0.952-1.006 | 0.120 | - | - | - |
| Triglyceride | 1.000 | 0.997-1.003 | 0.872 | - | - | - |
| BMI | 1.017 | 0.935-1.106 | 0.692 | - | - | - |
| LVEDD | 0.993 | 0.919-1.074 | 0.870 | - | - | - |
| LVESD | 1.032 | 0.961-1.108 | 0.385 | - | - | - |
| IVS thickness | 1.134 | 0.952-1.351 | 0.158 | - | - | - |
| Ejection fraction | 0.991 | 0.929-1.057 | 0.785 | - | - | - |
| Adenosine dosage | ||||||
| Heart rate | 1.009 | 0.984-1.035 | 0.468 | - | - | - |
| QRS duration | 0.987 | 0.952-1.023 | 0.479 | - | - | - |
| QT interval | ||||||
| QTc interval | 1.006 | 0.997-1.014 | 0.195 | - | - | - |
| Frontal QRS-T angle | ||||||
BMI - body mass index; FFR - fractional flow reserve; HDL - high-density lipoprotein; IVS - interventricular septum; LDL - low-density lipoprotein; LVEDD - left ventricle end-diastolic diameter; LVESD - left ventricle end-systolic diameter
Figure 3The correlation between QRSTa and both pre-adenosine and post-adenosine FFR values and IVS thickness
FFR - fractional flow reserve; IVS - interventricular thickness; QRSTa - QRS-T angle
Figure 4Receiver operating characteristic curves indicating the discriminative ability of the QRSTa
QRSTa- QRS-T angle